Cargando…
Identification of functional pathways for regenerative bioactivity of selected renal cells
BACKGROUND: Selected renal cells (SRC) are in Phase II clinical trials as a kidney-sourced, autologous, tubular epithelial cell-enriched cell-based therapy for chronic kidney disease (CKD). In preclinical studies with rodent models of CKD, SRC have been shown to positively modulate key renal biomark...
Autores principales: | Sha, Wei, Bertram, Timothy, Jain, Deepak, Brouwer, Cory, Basu, Joydeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851708/ https://www.ncbi.nlm.nih.gov/pubmed/35177125 http://dx.doi.org/10.1186/s13287-022-02713-6 |
Ejemplares similares
-
Organ specific regenerative markers in peri-organ adipose: kidney
por: Basu, Joydeep, et al.
Publicado: (2011) -
Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action With Cell Marker Analysis
por: Stavas, Joseph, et al.
Publicado: (2022) -
Selected renal cells harbor nephrogenic potential
por: Narayan, Prakash, et al.
Publicado: (2022) -
Mesoporous bioactive glasses for regenerative medicine
por: Vallet-Regi, M., et al.
Publicado: (2021) -
Regulation of stem cell fate and function by using bioactive materials with nanoarchitectonics for regenerative medicine
por: Hu, Wei, et al.
Publicado: (2022)